MARIT STINUS-CABUGON

IT was shocking to learn that the anti-dengue vaccine Dengvaxiawas administered to more than 700,000 Filipino children without having undergone sufficiently thorough testing. The vaccine, the first medicine of any kind against dengue, was developed by pharmaceutical company Sanofi-Pasteur. It received its first approval for marketing in December 2015, in Mexico. Eighteen other countries in Latin America and Asia-Pacific followed.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details